Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыДефектологияКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Королёва со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Antimicrobial drug resistance in Lower respiratory tract infection   Shyam Kumar Mishra

Antimicrobial drug resistance in Lower respiratory tract infection

256 страниц. 2013 год.
LAP Lambert Academic Publishing
The emergence of extended-spectrum beta-lactamase (ESBL)- and metallo-beta-lactamase (MBL)-producing bacteria causing lower respiratory tract infection (LRTI) has resulted in fewer therapeutic options in treatment modalities. No studies regarding MBLs had been done so far in Nepal and a few researches on ESBLs were also just pilot studies. Therefore, this study was carried out to determine the bacterial etiology of LRTI and to assess the current levels of antimicrobial resistance in Nepal. Combination disk and Double disk synergy test methods were used for the detection of ESBL- and MBL-producing bacteria. A high level of antibiotic resistance was seen. One-fourth of the gram-negative bacterial isolates were ESBL-producer. The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) was also relatively higher. Moreover, we isolated MBL-producing bacteria for the first time in Nepal. It is concluded that the problem of antimicrobial resistance is high in our set-up. It is...
 
- Генерация страницы: 0.04 секунд -